Not Yet RecruitingPhase 1ACTRN12606000111572

A randomised controlled trial of a letter intervention in primary care patients to improve depression and anxiety disorders

A randomised controlled trial of a letter intervention to assess psychiatric severity in primary care patients who have depressive and anxiety disorders

Sponsor

The Alfred Hospital

Enrollment

200 participants

Start Date

Jun 1, 2006

Study Type

Interventional

Conditions

DSM-IV Axis 1 Depressive and Anxiety Disorders

Summary

The purpose of the study is to investigate whether patients who receive a copy of the psychiatric assessement letter that is sent to their GP have improved adherence to treatment recommendations. There are two hypotheses: 1. receiving the assessment report will improve patient adherence to treatment recommendations; 2. that receiving the assessment report will improve patient outcomes.

Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying: A randomised controlled trial of a letter intervention in primary care patients to improve depression and anxiety disorders. It may be open to adults aged 18 and older who meet certain criteria, including: Primary depressive or anxiety disorder. Participation typically involves medical assessments, possible treatment with the study intervention, and follow-up visits to track your health.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Patients in experimental group receive a copy of the psychiatric assessment letter that is usually sent to the GP.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12606000111572